Skip to content
10-K

Annual Report

BIOVEST INTERNATIONAL INC

0001193125-12-514941

← back to feed
Filed
Dec 26, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Nov 30, 2012 146.51M sh
Capex FY 2012 · Sep 30, 2011 $749K
Operating Cash Flow FY 2012 · Sep 30, 2011 −$3.84M
Long Term Debt FY 2012 · Sep 30, 2011 $30.85M
Short Term Debt FY 2012 · Sep 30, 2011 $1.06M
Current Liabilities FY 2012 · Sep 30, 2011 $3.85M
Total Liabilities FY 2012 · Sep 30, 2011 $37.96M
Current Assets FY 2012 · Sep 30, 2011 $1.6M
Total Assets FY 2012 · Sep 30, 2011 $5.42M
Sga Expense FY 2012 · Sep 30, 2011 $10.17M
Rd Expense FY 2012 · Sep 30, 2011 $1.8M
Net Income FY 2012 · Sep 30, 2011 −$15.28M
Operating Income FY 2012 · Sep 30, 2011 −$10.58M
Cost Of Revenue FY 2012 · Sep 30, 2011 $2.49M
Revenue FY 2012 · Sep 30, 2011 $3.88M
Stockholders Equity restated FY 2012 · Sep 30, 2010 −$76.94M